Select Page
Home » Expert Content » Softgel Technology to Deliver Poorly Soluble APIs | Catalent in 90 Seconds

Softgel Technology to Deliver Poorly Soluble APIs | Catalent in 90 Seconds

Summary: The number of poorly soluble new drugs entering development has been estimated to be anywhere from 40% to 70%. Many companies are increasingly focusing their attention on the properties of their drug candidates (particularly solubility and permeability) to understand the impact on clinical exposure.

Softgel is the drug delivery solution of choice that solves complex formulation, solubility, bioavailability, and development challenges, bringing more molecules to market faster.

This technology has been increasingly applied across a wide range of applications including prescription medicines, consumer health, vitamins & mineral supplements and cosmetics.